Annovis Bio, Inc.ANVSNYSE
Loading
EV/EBITDA Over TimeContracting
Percentile Rank75
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
655.36
↓ 99% vs avg
Percentile
P75
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
126331.24
Historical baseline
PeriodValueYoY Change
2025655.36+34590.7%
2024-1.90+47.5%
2023-3.62-13.6%
2022-3.18+47.8%
2021-6.09-
20200.00+100.0%
2019-83.62-100.0%
2018638798.30+28.4%
2017497625.93-